{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:47:21Z","timestamp":1767016041675,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die blastische plasmazytoide dendritische Zellneoplasie ist eine seltene h\u00e4matologische Neoplasie, die aus Vorl\u00e4uferzellen der plasmazytoiden dendritischen Zellen entsteht und durch disseminierte, erythemat\u00f6se bis bl\u00e4ulich-livide Plaques oder Nodi gekennzeichnet ist. Aufgrund der Seltenheit der Erkrankung stellen die Diagnose und Therapie eine Herausforderung dar. Wir berichten \u00fcber einen Patienten mit BPDCN und stellen klinische und diagnostische Merkmale sowie Therapieoptionen vor.<\/jats:p>","DOI":"10.1007\/s00105-023-05192-9","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T17:01:57Z","timestamp":1688576517000},"page":"787-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blastische plasmazytoide dendritische Zellneoplasie (BPDCN)","Blastic plasmacytoid dendritic cell neoplasm (BPDCN)"],"prefix":"10.1007","volume":"74","author":[{"given":"Katrin","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f6ren","family":"Korsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"5192_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber\u00a0DA, Orazi\u00a0A, Hasserjian\u00a0R et\u00a0al (2016) The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391\u20132405","journal-title":"Blood"},{"key":"5192_CR2","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1182\/bloodadvances.2019000647","volume":"3","author":"F Garnache-Ottou","year":"2019","unstructured":"Garnache-Ottou\u00a0F, Vidal\u00a0C, Biichle\u00a0S et al (2019) How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Adv 3:4238\u20134251","journal-title":"Blood Adv"},{"key":"5192_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/bjd.12412","volume":"169","author":"F Julia","year":"2013","unstructured":"Julia\u00a0F, Petrella\u00a0T, Beylot-Barry\u00a0M et al (2013) Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90\u00a0patients. Br J Dermatol 169:579\u2013586","journal-title":"Br J Dermatol"},{"key":"5192_CR4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.bbmt.2013.01.027","volume":"19","author":"MA Kharfan-Dabaja","year":"2013","unstructured":"Kharfan-Dabaja\u00a0MA, Lazarus\u00a0HM, Nishihori\u00a0T et al (2013) Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a\u00a0focus on hematopoietic cell transplantation. Biol Blood Marrow Transplant 19:1006\u20131012","journal-title":"Biol Blood Marrow Transplant"},{"key":"5192_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11899-018-0489-z","volume":"13","author":"JD Khoury","year":"2018","unstructured":"Khoury\u00a0JD (2018) Blastic plasmacytoid dendritic cell neoplasm. Curr Hematol Malig Rep 13:477\u2013483","journal-title":"Curr Hematol Malig Rep"},{"key":"5192_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.2012.072645","volume":"98","author":"L Pagano","year":"2013","unstructured":"Pagano\u00a0L, Valentini\u00a0CG, Pulsoni\u00a0A et\u00a0al (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 98:239\u2013246","journal-title":"Haematologica"},{"key":"5192_CR7","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","volume":"380","author":"N Pemmaraju","year":"2019","unstructured":"Pemmaraju\u00a0N, Lane\u00a0AA, Sweet\u00a0KL et al (2019) Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm. N\u00a0Engl J Med 380:1628\u20131637","journal-title":"N Engl J Med"},{"key":"5192_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1182\/asheducation-2016.1.16","volume":"2016","author":"JM Sullivan","year":"2016","unstructured":"Sullivan\u00a0JM, Rizzieri\u00a0DA (2016) Treatment of blastic plasmacytoid dendritic cell neoplasm. Hematology Am Soc Hematol Educ Program 2016:16\u201323","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"5192_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood.2019001144","volume":"134","author":"J Taylor","year":"2019","unstructured":"Taylor\u00a0J, Haddadin\u00a0M, Upadhyay\u00a0VA et\u00a0al (2019) Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a\u00a0pretargeted therapy benchmark. Blood 134:678\u2013687","journal-title":"Blood"},{"key":"5192_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3324\/haematol.2020.247569","volume":"106","author":"W Wang","year":"2021","unstructured":"Wang\u00a0W, Khoury\u00a0JD, Miranda\u00a0RN et al (2021) Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a\u00a010-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm. Haematologica 106:1047\u20131055","journal-title":"Haematologica"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05192-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05192-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05192-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T13:02:17Z","timestamp":1695387737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05192-9"}},"subtitle":["Eine seltene h\u00e4matologische Neoplasie mit h\u00e4ufiger kutaner Beteiligung","A\u00a0rare hematologic neoplasm with frequent cutaneous involvement"],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["5192"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05192-9","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"13 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Nguyen, S.\u00a0Korsing, Y.\u00a0Mansour und K.\u00a0Meier geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}